Bypassing complement: evolutionary lessons and future implications
Open Access
- 1 May 2006
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (5) , 1215-1218
- https://doi.org/10.1172/jci28622
Abstract
Lectins like mannan-binding protein are part of the innate immune system. They circulate in association with serine proteases. Upon binding oligosaccharides, they activate the complement cascade analogous to the more familiar but evolutionarily more recent classical pathway, which is triggered by antibody binding to antigen. In this issue of the JCI, Selander et al. developed a sensitive and specific ELISA employing Salmonella-specific sugars to assess the activity of the lectin pathway of complement activation (see the related article beginning on page 1425). This more physiologic assay system allowed the investigators to rigorously define the requirements for lectin pathway activation. Furthermore, they uncovered an unsuspected means for this pathway to reach the desired critical step of activation of the opsonin C3. These types of functional assays will eventually replace the more laborious, less physiologic, and less informative approaches currently in use to monitor complement activation.Keywords
This publication has 13 references indexed in Scilit:
- Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2Journal of Clinical Investigation, 2006
- Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISAJournal of Immunological Methods, 2004
- IgG and Complement-Mediated Tissue Damage in the Absence of C2: Evidence of a Functionally Active C2-Bypass Pathway in a Guinea Pig ModelThe Journal of Immunology, 1999
- Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptomsArthritis & Rheumatism, 1998
- The mechanism of activation of the alternative pathway of complement by cell-bound C4bMolecular Immunology, 1990
- Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.The Journal of Immunology, 1989
- Mechanism of killing of Giardia lamblia trophozoites by complement.Journal of Clinical Investigation, 1987
- Alternative complement pathway activation by C4b deposited during classical pathway activation.The Journal of Immunology, 1986
- POSSIBLE CLQ BYPASS LOOP ACTIVATION IN THE HEMOLYTIC UREMIC SYNDROME1979
- Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.1973